4//SEC Filing
MAULDIN JOHN F 4
Accession 0001209191-19-019311
CIK 0001708599other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:53 PM ET
Size
5.3 KB
Accession
0001209191-19-019311
Insider Transaction Report
Form 4
MAULDIN JOHN F
Director
Transactions
- Award
Option to Pruchase Common Stock
2019-03-11+65,000→ 65,000 totalExercise: $4.28Exp: 2029-03-10→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]Options will become exercisable in four equal quarterly installments from the date of grant on March 11, 2019 provided that the grantee remains a director on the last day of the applicable calendar quarter.
Documents
Issuer
AgeX Therapeutics, Inc.
CIK 0001708599
Entity typeother
Related Parties
1- filerCIK 0001522480
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 8:53 PM ET
- Size
- 5.3 KB